Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold L Atkins

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study GroupMark S Freedman, Amit Bar-Or, Harold L Atkins, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2019
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MSSimon Thebault, Daniel R Tessier, Hyunwoo Lee, et al.
Brain : a Journal of Neurology|February 13, 2007
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosisImke Metz, Claudia F Lucchinetti, Harry Openshaw, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trialJason A Berard, Mark S Freedman, Ruth Ann Marrie, et al.
Annals of Neurology|July 28, 2010
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosisPeter J Darlington, Marie-Noëlle Boivin, Christel Renoux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitizationScott A Laurie, John C Bell, Harold L Atkins, et al.
European Journal of Haematology|October 24, 2024
Distance to CAR-T Treatment Center Does Not Impede DeliveryXiu Xia Sherry Tan, Melissa T Maltez, Ranjeeta Mallick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemiaDavid P Conrad, Jovian Tsang, Meaghan Maclean, et al.
Frontiers in Immunology|June 6, 2018
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple SclerosisPeter J Darlington, Brandon Stopnicki, Tarik Touil, et al.
JAMA Neurology|August 27, 2014
Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant programSheilagh Sanders, Christopher Bredeson, C Elizabeth Pringle, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study GroupMark S Freedman, Amit Bar-Or, Harold L Atkins, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2019
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MSSimon Thebault, Daniel R Tessier, Hyunwoo Lee, et al.
Brain : a Journal of Neurology|February 13, 2007
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosisImke Metz, Claudia F Lucchinetti, Harry Openshaw, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trialJason A Berard, Mark S Freedman, Ruth Ann Marrie, et al.
Annals of Neurology|July 28, 2010
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosisPeter J Darlington, Marie-Noëlle Boivin, Christel Renoux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitizationScott A Laurie, John C Bell, Harold L Atkins, et al.
European Journal of Haematology|October 24, 2024
Distance to CAR-T Treatment Center Does Not Impede DeliveryXiu Xia Sherry Tan, Melissa T Maltez, Ranjeeta Mallick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemiaDavid P Conrad, Jovian Tsang, Meaghan Maclean, et al.
Frontiers in Immunology|June 6, 2018
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple SclerosisPeter J Darlington, Brandon Stopnicki, Tarik Touil, et al.
JAMA Neurology|August 27, 2014
Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant programSheilagh Sanders, Christopher Bredeson, C Elizabeth Pringle, et al.
Pageof 5